Vergent Bioscience
PrivateLast Round
Grant
Nov 29, 2022
Total Funding Raised
$32.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Vergent Bioscience is a biotechnology company that develops tumor-targeted fluorescent imaging agents to improve the visibility of tumors for surgeons during minimally invasive and robotic-assisted surgery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vergent Bioscience Comparables
Compare Vergent Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Blaze Bioscience, Inc. | 93% | |
| On Target Laboratories | 89% | |
| Avelas Biosciences | 84% |
Vergent Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 29, 2022 | ||||
| Series B | Oct 4, 2022 | ||||
| Series A | Jun 12, 2018 |
Key People
Founding team and executive leadership
Vergent Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Orlando Health Ventures | Series B |
| Windham Capital Partners | Series B |
| Spring Mountain Capital | Series A |
| Rex Health Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Grew 27% QoQ from 11 to 14 employees.
- Jul 26, 2024
Grew 27% QoQ from 11 to 14 employees.
Vergent Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vergent Bioscience's valuation, stock price, and market status.
Is Vergent Bioscience a public or private company?
Vergent Bioscience is a private company.
What is the current stock price of Vergent Bioscience?
Vergent Bioscience is a private company, so its shares have no public market price. Caplight tracks Vergent Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vergent Bioscience worth (valuation)?
Valuation information for Vergent Bioscience is not publicly available.
Can I buy Vergent Bioscience stock?
Vergent Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vergent Bioscience's last funding round?
Vergent Bioscience's most recent funding round was Grant on November 29, 2022.
Who are the main investors in Vergent Bioscience?
Key investors in Vergent Bioscience include Orlando Health Ventures, Spring Mountain Capital.
Will Vergent Bioscience IPO soon?
No public IPO plans have been announced for Vergent Bioscience.
How can I track Vergent Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Vergent Bioscience's shares on secondary markets.